David Ereira OBE appointed as new chair of Myeloma UK

Myeloma UK is delighted to share the news that David Ereira OBE has been appointed as Chair of the Board of Trustees.

David, a partner at Quinn Emanuel Urquhart & Sullivan, LLP, has extensive experience working with the third sector and government agencies and is keen to help drive Myeloma UK forward and “rewrite the future for people affected by myeloma”.

“I’m delighted and honoured to be taking up the position of Chair of the Myeloma UK Board of Trustees,” said David, who was a trustee and acting chair of Marie Curie as well as chair of the Public Chairs Forum. “Over the relatively short period Myeloma UK has been in existence, it has really contributed to making a difference to people’s lives. Not only clinically but, as importantly, in providing support, guidance and a connection for people suffering from a still under-recognised disease.

“During my appointment conversations, I have been struck by how the work of the charity reflects the whole lifetime of an individual’s experience of myeloma. That concept of hope and support at every stage resonated deeply with me.” 

Dr Sophie Castell, Chief Executive at Myeloma UK, welcomed David’s appointment. She said: “We are delighted to welcome David to the charity and look forward to working with him as we build on our vision to provide treatments, information and support so anyone affected by myeloma can look to the future with confidence. David brings a wealth of experience and comprehensive understanding of the third sector to Myeloma UK. His commitment to putting people affected by myeloma at the very heart of decision-making is a natural fit and will stand us in good stead as we strive to achieve our goals and break down the many barriers facing people with myeloma.”

David’s appointment comes at a pivotal time for Myeloma UK, following the launch of our new strategy.

David added: “Joining at the start of the new strategy gives me the opportunity to support the charity as it makes the changes that will rewrite the future for people affected by myeloma. I’m also eager to meet people who make up our wider community: people affected by myeloma, clinicians, researchers and funders. This spirit of partnership, encapsulated by the new strategy, is one I am eager to see thrive.”

Close-up photograph of a hand holding a mobile phone.

Stay in touch

We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.